Ribavirin Therapy for Nipah Virus Infection

Authors: Guillaume, Cantamin, Loth, Georges-Courbot, Lefeuvre, Maraianneau, Chua, Lam, Buckland, Deubel, Wild

Year: 2004

Journal: Journal of Virology

DOI: 10.1128/JVI.78.18.10211.2004

Summary

This paper presents a study on the effectiveness of ribavirin therapy in treating Nipah virus infection in mice and humans, contradicting a previous statement that ribavirin was ineffective based on limited data.

Key Findings

• In an open-label study, mortality was significantly lower in patients with Nipah virus encephalitis treated with ribavirin compared to controls (32% vs. 54%, P ⫽ 0.011)
• Duration of ventilation and total hospital stay were both significantly shorter in the ribavirin group compared to controls (P ⫽ 0.0002 and <0.0001, respectively)

Methodology

• Study Type: Open-label study
• Sample Size: 140 patients with Nipah virus encephalitis
• Geographic Focus: Malaysia
• Time Period: 1998

Topics

Virology, Clinical

Relevance

The paper challenges a previous misleading statement about the ineffectiveness of ribavirin in treating Nipah virus infection, providing important information for future research.

Source

View the entire paper: File:0864-04.pdf